Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘hedge fund:647’

biotech research company, bio-technology companies

AxoGen and Blueprint Medicines Help Opaleye Return 91% Over the Last Year

James A. Silverman founded Opaleye Management back in 1996 and it was formerly known as Risk/Reward Capital. The fund invests primarily in healthcare......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13G Filing: Opaleye Management and Inotek Pharmaceuticals Corp (ITEK)

Inotek Pharmaceuticals Corp (NASDAQ:ITEK): James A. Silverman’s Opaleye Management filed an amended 13D. You can check out Opaleye Management’......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13G Filing: Opaleye Management and Tonix Pharmaceuticals Holding Corp. (TNXP)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 8 – SEC Filing       UNITED STATESSECURITIES AND EXCHANGE......(read more)
mri, doctor, physicians, display, treatment, idea, medic, experiment, pharmaceutical, patient, future, interface, laboratory, multimedia, intelligence, male, digital, scan,

This Healthcare Fund Just Had A Huge Q3: Here’s How

The mainstream media likes taking shots at hedge funds because they are easy targets. These investment vehicles are usually run by very wealthy individuals......(read more)

More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks

The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds......(read more)